GLP-1s and sleep: better, worse, or both?

The 30-second summary

• Weight loss improves sleep apnoea risk and overall sleep quality for many women. The SURMOUNT-OSA trial confirmed it for tirzepatide.
• But early in titration, some women report new or worsened reflux, vivid dreams, or fragmented sleep, all linked to slowed gastric emptying.
• The fix is rarely the drug; it is when, what, and how you eat in the four hours before bed.

The good news, in one trial

The SURMOUNT-OSA trial, published in 2024, randomised 469 adults with obstructive sleep apnoea and obesity to tirzepatide or placebo for 52 weeks. Tirzepatide reduced the apnoea-hypopnoea index (the standard measure of sleep apnoea severity) by about 25 events per hour versus a much smaller change in placebo. Many participants no longer met criteria for sleep apnoea at all by week 52. (Malhotra A et al., NEJM 2024.)

Weight loss has long been a first-line treatment for obstructive sleep apnoea. The SURMOUNT-OSA trial showed that the magnitude of weight loss achievable with a GLP-1 is sufficient to meaningfully change sleep-disordered breathing, for many women, to the point of resolving it.

If you have ever been told you snore, you wake up unrefreshed, your partner reports gasping or pauses in your breathing, this is news worth knowing.

The less good news: reflux and broken sleep

Early in titration, particularly in the first 12 weeks, some women on a GLP-1 develop a new or worsened pattern:

• Acid reflux at night, often waking them at 2–4am
• Vivid dreams or restless sleep
• Burping and bloating that persists overnight
• A heavy stomach feeling that prevents falling asleep

All of these trace back to one thing: slowed gastric emptying. The drug works by making your stomach hold food longer. When you lie down with a stomach that is still half-full of dinner, the contents press against the lower oesophageal sphincter, and reflux is the result.

The four-hour rule

The single most useful intervention for GLP-1 sleep disruption is finishing dinner at least four hours before bed. Not three. Not "an hour or two." Four.

For most women, this means:

• 10pm bedtime → dinner finished by 6pm
• 11pm bedtime → dinner finished by 7pm

This sounds extreme. It is extreme. It is also more effective than every other intervention combined for reflux on a GLP-1.

If a four-hour gap is impossible, the next levers in order of effectiveness:

1. Make dinner smaller. A 600-calorie dinner three hours before bed is worse than a 350-calorie dinner three hours before bed.
2. Reduce dietary fat at dinner. Fat slows gastric emptying further. A bowl of pasta empties faster than salmon and avocado.
3. Skip alcohol with dinner. Alcohol relaxes the lower oesophageal sphincter and amplifies reflux.
4. Elevate the head of your bed: by 6 to 8 inches (not just extra pillows, which fold the neck and make things worse). Bed risers under the head-end legs work well.
5. Sleep on your left side, not your right. The stomach's anatomy means left-side sleeping reduces reflux. This is well-established. (Khoury RM et al., Am J Gastroenterol 1999.)

When to think about reflux medication

If the four-hour rule plus left-side sleeping is not enough, this is a real conversation with your prescriber. The standard options:

• H2 blockers (famotidine, taken in the evening): gentle, well-tolerated, often enough
• Proton pump inhibitors (omeprazole, pantoprazole): more powerful, more side effects in long-term use; reserved for persistent reflux

These are not GLP-1 contraindications. They are commonly used alongside.

The vivid dreams

A smaller but real complaint: vivid, sometimes disturbing dreams in the first weeks of a GLP-1. The mechanism is unclear. The pattern usually resolves over 4 to 8 weeks as the body adapts.

If dreams are interfering with rest meaningfully, a few things help:

• Avoid screens for 90 minutes before bed. REM sleep is more vivid when the day's inputs are loud.
• Magnesium glycinate at dinner. Helps with sleep depth.
• Be patient. This is one of the GLP-1 side effects that most reliably fades on its own.

What to do if sleep is genuinely worse

If after 8 weeks of titration your sleep is consistently worse than it was before the medication, this is worth a real conversation:

1. Talk to your prescriber about pausing the titration. Sometimes staying at the current dose for an extra cycle lets the GI system catch up.
2. Consider whether reflux is the issue. If it is, a short trial of an H2 blocker often answers the question definitively.
3. Get a sleep study if symptoms suggest sleep apnoea. Snoring, witnessed apnoeas, morning headaches, falling asleep during the day.
4. Check thyroid function. Hypothyroidism produces a particular kind of unrefreshing sleep, and a GLP-1 can unmask it.

What Steady does with this

Sleep is logged as a daily check-in. Sleep quality alongside dinner timing, dinner size, symptoms, and dose escalation history shows the pattern that is rarely obvious from memory. Women who think the drug is "just keeping them up" sometimes find it is actually a 9pm dinner four days in a row.

Sources

1. Malhotra A et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. NEJM 2024;391:1193-1205. NEJM
2. Khoury RM et al. Influence of spontaneous sleep positions on nighttime recumbent reflux in patients with GERD. Am J Gastroenterol 1999. PubMed
3. Kahrilas PJ et al. AGA Clinical Practice Update on GERD. Gastroenterology 2022. Gastro

Medical disclaimer: Persistent sleep disruption or untreated reflux deserve evaluation, not an internet article. See our full medical disclaimer.